FMR LLC holds 2.43M Axcelis shares in Schedule 13G (NASDAQ: ACLS)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Axcelis Technologies Inc ownership filing: FMR LLC reports beneficial ownership of 2,431,120.88 shares of Common Stock, representing 7.9% of the class as of 03/31/2026. The filing lists sole voting power of 2,421,135 and sole dispositive power of 2,431,120.88.
Positive
- None.
Negative
- None.
Key Figures
Beneficial ownership: 2,431,120.88 shares
Percent of class: 7.9%
Sole voting power: 2,421,135 shares
+3 more
6 metrics
Beneficial ownership
2,431,120.88 shares
Amount beneficially owned as reported
Percent of class
7.9%
Percent of common stock as reported
Sole voting power
2,421,135 shares
Sole power to vote reported on cover
Sole dispositive power
2,431,120.88 shares
Sole power to dispose reported on cover
Reporting period date
03/31/2026
Date tied to ownership figures
Signature date
05/05/2026
Date signatures were executed on the filing
Key Terms
Schedule 13G, beneficially owned, sole dispositive power, power of attorney
4 terms
Schedule 13G regulatory
"Item 1. (a) Name of issuer: AXCELIS TECHNOLOGIES INC"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Item 4. (a) Amount beneficially owned: 2431120.88"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Item 4. (iii) Sole power to dispose: 2431120.88"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
power of attorney legal
"Duly authorized under Power of Attorney effective as of April 13, 2026"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
FAQ
What stake does FMR LLC report in Axcelis Technologies (ACLS)?
FMR LLC reports beneficial ownership of 2,431,120.88 shares, equal to 7.9% of Axcelis common stock as of 03/31/2026. The filing discloses sole voting power of 2,421,135 and sole dispositive power of 2,431,120.88.
Who signed the Schedule 13G for ACLS on behalf of FMR LLC?
The filing is signed by Richard Bourgelas, authorized under a power of attorney to act on behalf of FMR LLC and Abigail P. Johnson. The signature dates shown are 05/05/2026 and reference an effective power of attorney dated 04/13/2026.
Does the Schedule 13G indicate other persons hold over 5% of ACLS?
The filing states one or more other persons may have rights to proceeds or dividends, but notes no other person's interest in Axcelis common stock exceeds 5% of the outstanding shares, per Item 6 disclosures in the filing.